CAS: 1438-30-8; Netropsin

该化合物是一种自然产生的抗生素,是被称为细细的细细粘结器的化合物类别之一.它来自细菌* 链球菌网状杆菌* .网根原素的化学结构具有多胺骨骼特征,使其能与细小的DNA干柱进行具体互动,从而影响基因表达和表现出潜在的抗抗沙素特性.它的行动机制涉及对具体DNA序列的约束力,这可以抑制某些基因的转录.Netropsin已经研究过其潜在的治疗用途,特别是在癌症治疗和抗病毒剂方面.该化合物的特征是水中的溶性相对较低,可影响其生物利用率.此外,网根素已经展示了一系列生物活动,包括抗细菌和抗病毒效应,使其成为医药化学的一个主题.然而,它的临床用途因毒性和副作用而受到限制,因此引发了对更安全的类比和衍生物的不断研究.

结构式图片

欧盟法规

ECHA物质C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-6683189-B1
    优先权日:1996-02-26
    标 题 :Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
    发明人:DERVAN PETER B; BAIRD ELDON
    权利人:CALIFORNIA INST OF TECHN
    摘要:The present invention describes a novel method for the solid phase synthesis of polyamides containing imidazole and pyrrole carboxamides. The polyamides are prepared on a solid support from aromatic carboxylic acids and aromatic amines with high stepwise coupling yields (>99%), providing milligram quantities of highly pure polyamides. The present invention also describes the synthesis of analogs of the natural products Netropsin and Distamycin A, two antiviral antibiotics. The present invention also describes a novel method for the solid phase synthesis of imidazole and pyrrole carboxamide polyamide-oligonucleotide conjugates. This methodology will greatly increase both the complexity and quantity of minor-groove binding polyamides and minor-groove binding polyamide-oligonucleotide conjugates which can be synthesized and tested.

    专利号:EP-3378556-A1
    优先权日:2017-03-20
    标题 :Method for the preparation of a low unspecific binding-support for affinity chromatography and/or on-line synthesis of oligonucleotides
    发明人:PLATELLA CHIARA; MUSUMECI DOMENICA; AMATO JUSSARA; RANDAZZO ANTONIO; PAGANO BRUNO; MONTESARCHIO DANIELA
    权利人:PLATELLA CHIARA; MUSUMECI DOMENICA; AMATO JUSSARA; RANDAZZO ANTONIO; PAGANO BRUNO; MONTESARCHIO DANIELA
    摘要:A method for preparing functionalized solid supports to be used in the on-line synthesis of support-bound, fully deprotected secondary structure-forming oligonucleotides and/or for low unspecific binding affinity chromatography is disclosed.

    专利号:US-7157477-B2
    优先权日:2000-10-25
    标题 :Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis
    发明人:ZHANG MANHUA; XU SHANGJIE; WU TAO; CHEN SHEN; SHEN TAO
    权利人:INST OF PHOTOGRAPHIC CHEMISTRY
    摘要:The invention involves a methods and compositions for use in photodynamic therapy. Novel perylenequinone derivatives, conjugates comprising perylenequinone derivatives and a binding agent, and methods of treatment using these compositions are disclosed. The present invention relates to the field of photosensitizers possessing photodynamic activities. They possess high photodynamic activities and low dark toxicities, which makes them as more potent photodynamic agents than HPD against cancer and AIDS virus.

    专利号:WO-9741109-A1
    优先权日:1996-04-26
    标 题 :Synthesis of (±) - calicheamicinone, precursors, intermediates and derivatives
    发明人:CLIVE DERRICK L J; DAIGNEAULT SYLVAIN; BO YUNXIN; TAO YONG
    权利人:UNIV ALBERTA; CLIVE DERRICK L J; DAIGNEAULT SYLVAIN; BO YUNXIN; TAO YONG
    摘要:This invention relates to calicheamicinone and related compounds, and processes for the preparation of these compounds and derivatives or analogs thereof. Many of the products that can be synthesized using these compounds have antibiotic activity including, but not limited to, anticancer, antifungal or antimicrobial activity.

    专利号:US-2005080260-A1
    优先权日:2003-04-22
    标 题 :Preparation of prodrugs for selective drug delivery
    发明人:MILLS RANDELL L; WU GUO-ZHANG
    摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.

    专利号:US-7579167-B2
    优先权日:2002-10-08
    标题:Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof
    发明人:BLONDELET-ROUAULT MARIE-HELENE; DOMINGUEZ HELENE; DARBON-RONGERE EMMANUELLE; GERBAUD CLAUDE; GONDRAN ANNE; KARRAY FATMA; LACROIX PATRICIA; OESTREICHER-MERMET-BOUVIER NATHALIE; JEAN-LUC PERNODET; TUPHILE KARINE
    权利人:AVENTIS PHARMA S; CENTRE NAT RECH SCIENT
    摘要:The present invention relates to the isolation and identification of novel genes of the biosynthetic pathway for spiramycins and to novel polypeptides involved in this biosynthesis. The invention also relates to a method for producing these polypeptides. It also relates to the use of these genes for the purpose of increasing the levels of production and the purity of the spiramycin produced. The invention relates in particular to a microorganism which produces spiramycin I but which does not produce spiramycin II and III, and to the use of such a microorganism. The invention also relates to the use of the genes of the biosynthetic pathway for spiramycins for constructing mutants which can lead to the synthesis of novel antibiotics or to derived forms of spiramycins. The invention also relates to the molecules produced through the expression of these genes and to pharmacologically active compositions of a molecule produced through the expression of such genes.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Chung JH, Bhat A, Kim CJ, Yong D, Ryu CM. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii. Sci Rep. 2016 Jun 16;6:28168. doi: 10.1038/srep28168.
    2: Andronova VL, Grokhovsky SL, Surovaya AN, Gursky GV, Galegov GA. Effect of dimeric netropsin analogue 15Lys-bis-Nt and acyclovir on the reproduction of herpes simplex virus type 1. The search for variants of herpes virus with drug resistance to 15Lys-bis-Nt and acyclovir. Dokl Biochem Biophys. 2015;460:42-6. doi: 10.1134/S1607672915010123. Epub 2015 Mar 13. doi: 10.3390/molecules190811300. doi: 10.1021/jp408077m. Epub 2013 Dec 5. Russian. doi: 10.1080/07391102.2012.732343. Epub 2012 Nov 16.
    7: Andronova VL, Grokhovskiĭ SL, Deriabin PG, Gurskiĭ GV, Galegov GA, L'vov DK. [Antiherpetic activity of netropsin derivatives as tested in experiments in laboratory animals]. Vopr Virusol. 2012 Jul-Aug;57(4):24-6. Russian. Russian. doi: 10.1002/jcc.22879. Epub 2012 Jan 7. doi: 10.1093/nar/gkr699. Epub 2011 Sep 3.

    合成参考文献


    参考文献:10.1021/jm00157a016
    摘要:Lown JW, Krowicki K, Balzarini J, De Clercq E. Structure-activity relationship of novel oligopeptide antiviral and antitumor agents related to netropsin and distamycin. J Med Chem. 1986 Jul;29(7):1210–4. doi: 10.1021/jm00157a016.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知